ONCRUnknown

Oncorus, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Oncorus, Inc. (ONCR), sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Are ONCR insiders buying or selling?

Oncorus, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since October 2020, Trabud has recorded 20 Form 4 filings for ONCR: 12 buys ($35.6M) and 8 sells ($1.3M).

Source: SEC EDGAR Form 4

Key Statistics (October 2020 – Dec 31, 2022)

Total Form 4 filings
20
SEC EDGAR
Insider filers
9
Insider buys (12)
$35.6M
Insider sells (8)
$1.3M

Insider sentiment

Net buying

Net insider flow of $34.3M in net buying since October 2020.

Recent ONCR insider transactions

DateInsiderRoleTypeSharesPriceValueFiling
Dec 31, 2022Flynn James EOther, 10% OwnerSale336.2K$0.26$88.3KSEC ↗
Dec 27, 2022Flynn James EOther, 10% OwnerSale73.4K$0.27$19.9KSEC ↗
Dec 22, 2022Flynn James EOther, 10% OwnerSale128.3K$0.29$37.6KSEC ↗
Dec 15, 2022Flynn James EOther, 10% OwnerSale13.8K$0.39$5.3KSEC ↗
May 25, 2022Rick WanstallCFO and TreasurerPurchase3.8K$1.20$4.5KSEC ↗
May 24, 2022Rick WanstallCFO and TreasurerPurchase1.6K$1.20$1.9KSEC ↗
May 19, 2022Rick WanstallCFO and TreasurerPurchase5.0K$1.29$6.5KSEC ↗
May 16, 2022Rick WanstallCFO and TreasurerPurchase38.6K$1.14$44.0KSEC ↗
Nov 17, 2021Stephen HarbinCOO and Chief of StaffPurchase30.0K$5.79$173.7KSEC ↗
Jun 3, 2021Christophe QuevaCSO and SVP, ResearchSale23.6K$16.68$392.8KSEC ↗
May 4, 2021Christophe QuevaCSO and SVP, ResearchSale23.6K$15.97$376.1KSEC ↗
Apr 28, 2021Christophe QuevaCSO and SVP, ResearchSale18.3K$15.22$277.8KSEC ↗
Apr 8, 2021Christophe QuevaCSO and SVP, ResearchSale5.3K$15.01$79.6KSEC ↗
Feb 18, 2021Flynn James EDirector, 10% OwnerPurchase300.0K$19.00$5.7MSEC ↗
Oct 8, 2020MPM SunStates Fund, L.P.10% OwnerPurchase173.8K$15.00$2.6MSEC ↗
Oct 8, 2020MPM BioVentures 2014, L.P.10% OwnerPurchase173.8K$15.00$2.6MSEC ↗
Oct 8, 2020Ansbert Gadicke10% OwnerPurchase325.0K$15.00$4.9MSEC ↗
Oct 8, 2020Luke EvninDirector, 10% OwnerPurchase151.2K$15.00$2.3MSEC ↗
Oct 8, 2020UBS Oncology Impact Fund L.P.10% OwnerPurchase151.2K$15.00$2.3MSEC ↗
Oct 8, 2020James E FlynnDirector, 10% OwnerPurchase1.0M$15.00$15.0MSEC ↗

Showing the 20 most recent of 20 Form 4 filings for Oncorus, Inc..

Most active ONCR insiders

Ask anything about ONCR insider activity

Use Trabud's AI agent to query Oncorus, Inc.'s Form 4 history in plain English — "Show me ONCR CEO purchases this year" or compare it against any other ticker.

Open the AI agent

ONCR insider trading FAQ

Are Oncorus, Inc. insiders buying or selling?

Oncorus, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since October 2020, Trabud has recorded 20 Form 4 filings for ONCR: 12 buys ($35.6M) and 8 sells ($1.3M). Over the full record that is net buying of $34.3M.

How many insiders trade ONCR stock?

9 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Oncorus, Inc.. The most recent filing was accepted on Dec 31, 2022.

Where does Trabud get ONCR insider trading data?

All ONCR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Related Content